Invion Ltd
IVX
Company Profile
Business description
Invion Ltd is an Australian clinical-stage pharmaceutical drug development company. It is engaged in the development of PhotoDynamic Therapy (PDT) for cancer treatments. The company produces topical and intravenous products suitable for use in skin cancer and solid tumors, such as ovarian, prostate, and lung cancer.
Contact
692 High Street
East Kew VIC 3102
AUSSector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2024
Employees
4
Stocks News & Analysis
stocks
3 undervalued US growth shares with moats
Growth continues to capitivate investors but care should be taken to not overpay.
stocks
BHP lobs all-share proposal for Anglo American
Our view on the potential acquisition and what BHP gets with Anglo American
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,906.60 | 69.20 | 0.88% |
| CAC 40 | 8,105.96 | 17.72 | 0.22% |
| DAX 40 | 18,190.63 | 29.62 | 0.16% |
| Dow JONES (US) | 38,239.66 | 153.86 | 0.40% |
| FTSE 100 | 8,175.90 | 36.07 | 0.44% |
| HKSE | 17,746.91 | 95.76 | 0.54% |
| NASDAQ | 15,927.90 | 316.14 | 2.03% |
| Nikkei 225 | 37,934.76 | 306.28 | 0.81% |
| NZX 50 Index | 11,916.24 | 111.15 | 0.94% |
| S&P 500 | 5,099.96 | 51.54 | 1.02% |
| S&P/ASX 200 | 7,637.40 | 61.50 | 0.81% |
| SSE Composite Index | 3,113.04 | 24.41 | 0.79% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| The Star Entertainment Group Ltd SGR | 0.42 | 0.03 | 6.41% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Droneshield Ltd DRO | 0.80 | 0.04 | -4.22% |
| Mesoblast Ltd MSB | 1.09 | 0.16 | 16.67% |
| South32 Ltd S32 | 3.51 | 0.14 | 4.15% |
| Pilbara Minerals Ltd PLS | 3.96 | 0.16 | 4.21% |
| Telstra Group Ltd TLS | 3.66 | 0.02 | 0.55% |
| Northern Minerals Ltd NTU | 0.03 | 0.00 | 6.25% |
| Jupiter Mines Ltd JMS | 0.32 | 0.02 | 5.00% |
| Imugene Ltd IMU | 0.08 | 0.00 | 3.80% |